Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2020
Reporting Period: Single event date (March 10, 2020)
Business Context: The registrant is an emerging growth company incorporated in Delaware. This filing serves as a Regulation FD disclosure regarding upcoming investor and analyst presentations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the use of an investor presentation (Exhibit 99.1) and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document solely announces the intent of executive officers to utilize the March 2020 Investor Presentation for upcoming communications with investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: Executive officers plan to use the material in Exhibit 99.1 for investor presentations.
Regulatory Status: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated March 2020) for actual financial data and strategic outlook.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbol (KIDS) and exchange (Nasdaq Global Market) for the Common Stock.